Interventional management of in-stent thrombosis after superior mesenteric vein stenting

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months' follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagulation is helpful to avoid subsequent in-stent thrombosis.

Original languageEnglish
JournalEJVES Extra
Volume22
Issue number3
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Mesenteric Veins
Stents
Thrombosis
Polytetrafluoroethylene
Pathologic Constriction
Transplants
Blood Vessels
Heparin
Therapeutics

Keywords

  • Direct thrombolysis
  • Mesenteric vein stenosis
  • Stenting

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Interventional management of in-stent thrombosis after superior mesenteric vein stenting. / Mauri, G.; Monti, L.; Pedicini, V.

In: EJVES Extra, Vol. 22, No. 3, 09.2011.

Research output: Contribution to journalArticle

@article{145f52d465424eec9c15825dde1cd492,
title = "Interventional management of in-stent thrombosis after superior mesenteric vein stenting",
abstract = "Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months' follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagulation is helpful to avoid subsequent in-stent thrombosis.",
keywords = "Direct thrombolysis, Mesenteric vein stenosis, Stenting",
author = "G. Mauri and L. Monti and V. Pedicini",
year = "2011",
month = "9",
doi = "10.1016/j.ejvsextra.2011.06.005",
language = "English",
volume = "22",
journal = "EJVES Extra",
issn = "1533-3167",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Interventional management of in-stent thrombosis after superior mesenteric vein stenting

AU - Mauri, G.

AU - Monti, L.

AU - Pedicini, V.

PY - 2011/9

Y1 - 2011/9

N2 - Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months' follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagulation is helpful to avoid subsequent in-stent thrombosis.

AB - Introduction: Mesenteric vein stenosis and thrombosis are rare conditions, without a definite treatment strategy. Report: A 46 year-old man underwent pancreatic resection with a polytetrafluoroethylene (PTFE) graft vascular reconstruction; he subsequently developed anastomotic mesenteric vein stenosis, which was treated with transhepatic venoplasty and stenting. Three months later, he suffered an in-stent thrombosis, after a reduction in heparin dosage. The thrombosis was successfully managed, after a failed systemic thrombolysis, with a direct thrombolysis via transjugular approach. At 10 months' follow-up, the stent was still patent. Conclusion: Mesenteric vein stenting is effective on PTFE grafts, but appropriate anticoagulation is helpful to avoid subsequent in-stent thrombosis.

KW - Direct thrombolysis

KW - Mesenteric vein stenosis

KW - Stenting

UR - http://www.scopus.com/inward/record.url?scp=84860287765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860287765&partnerID=8YFLogxK

U2 - 10.1016/j.ejvsextra.2011.06.005

DO - 10.1016/j.ejvsextra.2011.06.005

M3 - Article

VL - 22

JO - EJVES Extra

JF - EJVES Extra

SN - 1533-3167

IS - 3

ER -